Cough Medicine for Patients with Tracheostomy
Avoid traditional oral cough suppressants and expectorants in tracheostomy patients, as the cough reflex serves a critical protective function to clear secretions and prevent life-threatening tube obstruction. Instead, focus on optimizing secretion management through proper humidification, closed-circuit suctioning techniques, and when necessary, nebulized mucolytics delivered directly through the tracheostomy tube 1, 2.
Why Traditional Cough Medicines Are Not Recommended
- Suppressing the cough reflex in tracheostomy patients is dangerous because mucus plugging is one of the most common causes of airway emergencies and respiratory arrest in this population 1.
- The cough mechanism helps clear thick, tenacious secretions that accumulate in the airway, and blocking this protective reflex increases obstruction risk 1.
- Oral medications bypass the tracheostomy and have minimal effect on the lower airway where secretions accumulate 1.
Proper Secretion Management Approach
First-Line: Humidification and Suctioning
- Use Heat Moisture Exchangers (HMEs) with viral filters as the primary method to maintain airway moisture and reduce secretion thickness 1, 3.
- Perform frequent closed-circuit suctioning with inline suction catheters to prevent mucus buildup before it causes obstruction 1, 2.
- Avoid instilling saline before suctioning, as this increases coughing and aerosolization with little evidence of benefit 1, 2.
When Secretions Remain Problematic
- For mechanically ventilated patients with thick secretions requiring medication, use vibrating mesh nebulizers that maintain closed-circuit systems rather than jet nebulizers 1.
- For non-ventilated patients, deliver metered-dose inhaled medications via tracheostomy using a spacer 1.
- Jet nebulizers should be avoided as they aerosolize particles up to 80cm and increase infection transmission risk 1.
Mucolytic Therapy: Acetylcysteine
If secretions remain thick despite optimal humidification, nebulized acetylcysteine (Mucomyst) can be administered directly through the tracheostomy tube, though this is not FDA-approved specifically for routine tracheostomy care 4.
Dosing and Administration
- For nebulization through tracheostomy: 3-5 mL of 20% solution or 6-10 mL of 10% solution, 3-4 times daily 4.
- For direct instillation into tracheostomy for routine nursing care: 1-2 mL of 10-20% solution every 1-4 hours 4.
- The 20% solution may be diluted with sterile saline or sterile water; the 10% solution can be used undiluted 4.
Critical Safety Considerations
- The American Thoracic Society warns that medications not approved for aerosol use may achieve toxic concentrations when given via tracheostomy because all drug enters the respiratory tract without first-pass metabolism 1, 2.
- After acetylcysteine administration, thorough suctioning is essential to remove liquefied secretions 5.
- Store opened vials refrigerated and use within 96 hours to prevent contamination 4.
Mechanical Cough Assistance
- For patients with neuromuscular disease and ineffective cough, mechanical insufflation-exsufflation devices (Cough Assist) should be used in addition to standard techniques 3, 6.
- These devices substitute for glottis function and significantly increase cough peak flow compared to unassisted efforts 6.
- When using mechanical cough assist devices, attach a HEPA filter to prevent aerosolization 1.
Common Pitfalls to Avoid
- Never use medications not FDA-approved for tracheostomy administration without appropriate safety studies, as distribution, absorption, and toxicity profiles differ significantly from oral administration 1, 2.
- Do not use topical lidocaine routinely to suppress cough—reserve this only for specific procedures like tube changes, with careful attention to weight-based dosing in pediatric patients 1, 3.
- Avoid rigid devices like bougies during suctioning attempts, as these can create false passages 2, 5.
- Do not neglect proper PPE during any suctioning or medication administration, as these are high-risk aerosol-generating procedures 1, 2.
When to Escalate Care
- If thick secretions cause recurrent occlusion of inline circuits despite optimal management, place patients in negative pressure rooms or rooms with HEPA filters 1, 2.
- If obstruction occurs despite preventive measures, immediately remove external attachments and inner cannula, attempt suctioning, and prepare for emergency tube change if needed 5.